Graphene FET seeks biomedical partners

The Graphene FET Flagship has launched an open invitation for Expressions of Interest for new industrial partners working on Biomedical Technologies.

According to the Flagship, selected partners will become part of the scientific and technological work packages of the first core project, as part of Horizon 2020. The EU R&I framework programme phase will run from 1 April 2016 – 31 March 2018.

The Graphene Flagship says: “The utilisation of GRM and their properties in specific medical applications constitutes a key remit in the next Horizon 2020 phase of the Graphene Flagship. The technology area that the core project will emphasise during its initial phase is in the design of new-generation biomedical implants with the intention to spatially and temporally interrogate neural circuits of interest and therapeutically intervene at specific nodal points that will provide tailored therapeutic interventions.

“The potential of such interventions can be envisaged as first-line treatment options alongside small molecules, biopharmaceuticals and vaccines, or offer synergistic benefits that will address key health care issues of non-compliance/adherence to current medical treatments.”

The call is open until 6 March 2015.